摘要
继发性甲状旁腺功能亢进(secondary hyperparathyroidism,SHPT)是慢性肾衰竭患者常见的并发症,并且严重影响患者的生活质量。研究显示:严重的SHPT与患者的不良预后相关。因此,早期监测,及时、有效的治疗是十分重要的。对于药物难以控制的SHPT则需要手术治疗。现报告1例终末期肾脏病血液透析患者合并SHPT的治疗经过,以提高对这一并发症的认识。
出处
《中国血液净化》
2014年第6期482-484,共3页
Chinese Journal of Blood Purification
参考文献14
-
1Martinez I,Saracho R,Montenegro J,et al.A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism [J].Nephrol Dial Transplant,1996,11Suppl 3:22-28.
-
2Owda A,Elhwairis H,Narra S,et al.Secondary hyper-parathyroidism in chronic hemodialysis patients:preva fence and race[J].Ren Fail,2003,25:595-602.
-
3Noordzij M,Cranenburg EM,Engelsman LF,et al.Progres-sion of aortic calcification is associated with disor-ders of mineral metabolism and mortality in chronic di alysis patients[J].Nephrol Dial Transplant,2011,26:1662-1669.
-
4Slinin Y,Foley RN,Collins AJ.Calcium,phosphorus,parathyroid hormone,and cardiovascular disease in he-modialysis patients:the USRDS waves 1,3,and 4 study [J].J Am Soc Nephrol,2005,16:1788-1793.
-
5Li D,Shao L,Zhou H,et al.The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyper-parathyroidism:a meta-analysis[J].Endocrine,2013,43:68-77.
-
6Zhang Q,Li M,You L,et al.Effects and safety of cal-cimimetics in end stage renal disease patients with secondary hyperparathyroidism:a meta-analysis[J].PLoS One,2012,7:e48070.
-
7Cunningham J,Danese M,Olson K,et al.Effects of the calcimimetie cinacalcet HCI on cardiovascular disease,fracture,and health-related quality of life in second-ary hyperparathyroidism[J].Kidney lnt,2005,68:1793-1800.
-
8Tominaga Y,Tanaka Y,Sato K,et al.Histopathology,pathophysiology,and indications for surgical treat ment of renal hyperparathyroidism[J].Semin Surg On-col,1997,13:78-86.
-
9Ritz E.Which is the preferred treatment of advanced hy-perparathyroidism in a renal patient? Ⅱ.Early para-thyroidectomy should be considered as the first choice [J].Nephrol Dial Transplant,1994,9:1819-1821.
-
10Jofre R,Lopez Gomez JM,Menarguez J,et al.Parathy roidectomy:whom and when?[J].Kidney Int Suppl,2003:S97-100.
同被引文献21
-
1桑大华,王磊.高通量血液透析及血液透析滤过对老年尿毒症患者继发性甲状旁腺功能亢进症治疗效果比较[J].中国老年学杂志,2014,34(2):509-510. 被引量:31
-
2董青,李堂,姜红.新生儿原发性甲状旁腺功能亢进症1例报告及文献复习[J].临床儿科杂志,2006,24(8):661-662. 被引量:1
-
3ROIZENA J, LEVINEB M A. Primary hyperparathyroidism inchildren and adolescents [ J]. J Chin Med Assoc,2012,75(9):425-434.
-
4KULKARNI A,MOHITE M,VIJAYKUMAR R, et al. Neonatalsevere hyperparathyroidism due to compound heterozygous mutationof calcium sensing receptor ( CaSR ) gene presenting asencephalopathy [J]. Indian J Pediatr, 2014, 81(11) : 1228-1229.
-
5LIETMAN S A, TENENBAUM-RAKOVER Y,JAP T S,et al. Anovel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomalrecessive inheritance of familial hypocalciuric hypercalcemia [ J].J Clin Endocrinol Metab, 2009, 94(11) : 43724379.
-
6GARCIA SOBLECHEROE, FERRER CASTILLO M T, JIM6NEZCRESPO B, et al. Neonatal hypercalcemia due to a homozygousmutation in the calcium-sensing receptor : failure of cinacalcet[J]. Neonatology, 2013,104(2) : 104-108.
-
7GANNON A W, MONK H M,LEVINE M A. Cinacalcetmonotherapy in neonatal severe hyperparathyroidism : a case studyand review [ J]. J Clin Endocrinol Metab, 2014,99(1) : 7-11.
-
8REH C M, HENDY G N, COLE D E, et al. Neonatalhyperparathyroidism with a heterozygous calcium-sensing receptor(CaSR) R185Q mutation: clinical benefit from cinacalcet [J]. JClin Endocrinol Metab, 2011, 96(4) ; E707-E712.
-
9ATAY Z, BEREKET A,HALILOGLU B, et al. Novelhomozygous inactivating mutation of the calcium-sensing receptorgene ( CaSR) in neonatal severe hyperparathyroidism-lack ofeffect of cinacalcet [ J]. Bone, 2014, 64: 102-107. doi: 10.1016/j. bone. 2014. 04.010.
-
10夏发达,梁慧文,李劲东,黄云,王卓路,冯铁成,周宇帆,王志明,李新营.45例甲状旁腺肿瘤临床分析[J].中国普通外科杂志,2013,22(5):613-617. 被引量:11
引证文献3
-
1马震生.血液透析联合血液灌流治疗慢性肾衰竭并发继发性甲状旁腺功能亢进临床观察[J].现代诊断与治疗,2015,26(18):4092-4093. 被引量:7
-
2卢维城,郑旭,林静,陈兴月,魏海波.新生儿甲状旁腺功能亢进症1例报道并文献复习[J].儿科药学杂志,2016,22(2). 被引量:1
-
3高恒元,许楠,林俊清,周冬仙,刘新杰.甲状旁腺全切除与次全切除术治疗尿毒症继发性甲状旁腺功能亢进的疗效分析[J].慢性病学杂志,2017,17(8):871-873. 被引量:4
二级引证文献12
-
1段梦莲,陈创,孙圣荣.50例尿毒症继发性甲状旁腺功能亢进患者的手术疗效分析[J].中国普外基础与临床杂志,2019,26(1):61-66. 被引量:11
-
2匡彬.西那卡塞联合骨化三醇对血透患者继发性甲状旁腺功能亢进的治疗效果研究[J].现代诊断与治疗,2016,27(10):1771-1773. 被引量:20
-
3丁晓颖,曾玉纯,张俊涛.血液透析联合血液灌流治疗慢性肾衰竭合并继发性甲状旁腺功能亢进的疗效观察[J].吉林医学,2017,38(2):311-312. 被引量:16
-
4邱蕾.血液透析联合血液灌流治疗继发性甲状旁腺功能亢进疗效分析[J].淮海医药,2017,35(3):293-295. 被引量:3
-
5吴智鹏.用西那卡塞联合骨化三醇对慢性肾衰竭并发矿物质-骨代谢异常患者进行治疗的效果探究[J].当代医药论丛,2018,16(6):107-109. 被引量:2
-
6程锦绣,陆继芳,李玥欣,楚德英,王琳琳,刘翠兰,刘圣君,刘华.尿毒清颗粒对腹膜透析患者临床疗效的影响[J].安徽医药,2018,22(10):1997-2000. 被引量:10
-
7梁子介,侯爱珍,肖观清,孔耀中,张剑利.甲状旁腺全切除加前臂移植术治疗对尿毒症继发性甲状旁腺功能亢进成纤维生长因子23及骨代谢观察[J].中国医学创新,2018,15(19):12-15. 被引量:2
-
8邱焕珍.血液透析联合血液灌流治疗慢性肾衰竭的安全性及对患者肾功能指标的影响[J].当代医药论丛,2020,18(13):32-33. 被引量:3
-
9蒋雪峰,罗文荣.慢性肾功能衰竭血液透析并发甲状旁腺功能亢进患者PTH、FGF23、1,25(OH)2D3水平及临床意义[J].中国高等医学教育,2020(7):139-139.
-
10杨钱,高云瀚,李中福,胡淞.甲状旁腺次全切除术治疗维持性血液透析继发甲状旁腺功能亢进的短期疗效[J].检验医学与临床,2021,18(16):2395-2397. 被引量:1
-
1王文博,张凌,笪冀平,卞维静,李文歌.继发性甲状旁腺功能亢进症患者维生素D受体和钙敏感受体的免疫组化研究[J].中国血液净化,2011,10(5):265-269. 被引量:14
-
2于跃,张凌,姚力,王银娜,孙懿.继发性甲状旁腺功能亢进症行甲状旁腺切除术后并发甲状腺功能亢进1例[J].中国血液净化,2014,13(12):864-866. 被引量:6
-
3刘东,高卓,魏学明,李新伦,缪静,伦立德.甲状旁腺切除治疗尿毒症继发性甲状旁腺功能亢进症患者皮肤瘙痒的临床观察[J].中国血液净化,2014,13(3):134-136. 被引量:20
-
4张凌,王文博,姚力,卞维静,陈少轩.甲状旁腺全切除加前臂移植术后继发性甲状旁腺功能亢进症复发1例[J].中国血液净化,2011,10(5):277-278. 被引量:12
-
5伦立德,刘东,高卓,李新伦,魏学明,胡瑞海,缪静.甲状旁腺切除对尿毒症继发性甲状旁腺功能亢进症患者生存质量的影响[J].中国血液净化,2014,13(1):23-26. 被引量:28
-
6刘东,魏学明,高卓,李新伦,胡瑞海,李红霞,缪静,伦立德.甲状旁腺切除对继发性甲状旁腺功能亢进症患者左心室肥厚的影响[J].中国血液净化,2014,13(6):462-465. 被引量:6
-
7陈今,余毅,孙淑清,王琰,黄睿.骨化三醇治疗血液透析患者继发性甲状旁腺功能亢进症的临床观察[J].中国血液净化,2011,10(9):497-499. 被引量:16
-
8刘凤菊,勇强,程虹,卞维静.维持性血液透析患者甲状旁腺超声筛查的临床意义[J].中国血液净化,2014,13(3):143-145. 被引量:1
-
9游振辉,肖雪明,陈峰,顾恩郁,王沆,李华水,张爱龙,林强.带血管蒂甲状旁腺自体移植治疗继发性甲状旁腺功能亢进症3例[J].福建医科大学学报,2010,44(3):230-230. 被引量:1
-
10赵文燕,张凌,谢亚平,苏默,周莉,李文歌,卞维静.甲状旁腺切除术改善继发性甲状旁腺功能亢进症维持性血液透析患者生活质量[J].中国血液净化,2011,10(5):250-253. 被引量:45